Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe history now shows the trial is no longer recruiting participants, signaling the end of enrollment. It also records a new revision label v3.6.0 and removes the previous label v3.5.5 from the history.SummaryDifference0.4%

- Check16 days agoChange DetectedThe latest revision label in the study record history changed from v3.5.4 to v3.5.5, indicating an update to the page’s underlying record version.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision history now includes a new version labeled v3.5.4. The previous version v3.5.3 is removed, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page’s revision/version identifier updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a change to the website’s software version without altering the study record information.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded 'Results Submission Events (1)' and 'Revision: v3.5.2'; removed 'Revision: v3.5.0' from the history.SummaryDifference0.3%

- Check80 days agoChange DetectedAddition of 'Results Submitted' and removal of 'No Results Posted' are reflected in the study record history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.